Aug 9, 2020
New drug RLF-100 shows dramatic recovery in COVID-19 patients suffering respiratory failure
New drug RLF-100 shows dramatic recovery in COVID-19 patients suffering respiratory failure
HOUSTON: Doctors at a hospital here have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill COVID-19 patients.
The drug has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA’s Phase 2/3 trials.
Houston Methodist Hospital was the first to report the…
View On WordPress